Lords Mark Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-11-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.30 Cr
as on 16-11-2024
About Lords Mark Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹16.30 Cr.
Sachidanand Upadhyay and Manav Teli serve as directors at the Company.
- CIN/LLPIN
U24290MH2022PTC393233
- Company No.
393233
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lords Mark Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachidanand Upadhyay  | Director | 10-Nov-2022 | Current |
| Manav Teli | Director | 10-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Lords Mark Biotech.
Lords Mark Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lords Mark Biotech?
In 2023, Lords Mark Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lord's Mark Industries LimitedActive 26 years 5 monthsSachidanand Upadhyay and Manav Teli are mutual person
- Brahamastra Defence Techno Products LimitedActive 2 years 5 months
Sachidanand Upadhyay is a mutual person
- Lords Mark Insurance Broking Services Private LimitedActive 3 years 5 days
Sachidanand Upadhyay is a mutual person
Pavanputra Petroleum Services Private LimitedActive 11 months 21 daysSachidanand Upadhyay and Manav Teli are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 30 Sep 2023 | ₹3.00 Cr | Open |
Others Creation Date: 23 Mar 2023 | ₹13.30 Cr | Open |
How Many Employees Work at Lords Mark Biotech?
Unlock and access historical data on people associated with Lords Mark Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lords Mark Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lords Mark Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
